Juvena shares updates with the DM community about our muscle regenerating fusion protein, JUV-161 in the “Meet the Myotonic Dystrophy Drug Developers” webinar
CEO Dr. Yousef represents Juvena as a Technology Pioneer at at the World Economic Forum’s Annual Meeting of the New Champions, a.k.a. Summer Davos, in Dalian, China, speaking on “Revolutionary Remedies” and “Letting Biotech Breath”
CEO Dr. Hanadie Yousef represents Juvena on 2 panels at BIO San Diego to discuss navigating the frontiers of First-in-Class therapeutics, and how healthspan promoting therapeutics are entering the biopharma mainstream.
Wuxi spotlights Juvena in their BOLD: Innovation that Matters episode 3 focused on rare diseases. Check out Hanadie’s preview of Juvena’s JUV-161 program (1:58)
Juvena’a CEO, Dr. Hanadie Yousef discusses “Harnessing the Regenerative Secretome of Human Pluripotent Stem Cells” with other industry leaders discussing key areas of innovation advancing human healthspan and longevity at the Second Annual Longevity Summit
Annual BioFuture 2022 Event Recognizes Juvena CEO Dr. Hanadie Yousef Among Longevity Pioneers Shaping Expectations in Healthcare and Celebrates the Company’s Series A Announcement
